Home  Home | Contact us | How to find us | News | Accessibility Text-to-speech & translation
A member of Cambridge University Health Partners - www.cuhp.org.uk

News

« Back

1 May 2014

New Papworth Hospital gets go ahead

Papworth Hospital welcomes the announcement today that the business case for the relocation of Papworth Hospital to the Cambridge Biomedical Campus has been approved by HM Treasury.

“We are delighted to hear that the Chief Secretary to the Treasury, Danny Alexander MP, and Chancellor of the Exchequer, George Osborne, have today signed off the business case for the New Papworth Hospital project, following Mr Osborne’s pledge of personal support for the project on Friday.

“For many years we have been convinced that the right place for this world class institution to provide high-quality services for patients with heart and lung conditions from across the country is on the Cambridge Biomedical Campus. We now look forward to putting that vision into reality." said Professor John Wallwork, Chairman of Papworth Hospital and former cardiac surgeon.

The designs for the new hospital were unveiled in December and this approval allows the hospital to work with Skanska to further develop its plans and prepare a final business case and with the aim of starting construction on the new hospital at the end of this year.

The clinical and research case for the new hospital is beyond doubt and as well as providing the highest quality heart and lung services for patients with heart and lung conditions, it will be a key component of the vibrant biomedical cluster in Cambridge  which contributes greatly to the UK economy.

Last week the Chancellor pledged his support for the project stating that there is a “very strong case in bringing these two institutions more closely together, creating a hub of leading-edge medicine, research and pharmaceutical development”.

Professor John Wallwork, Chairman of Papworth Hospital, said: “Over recent months there has been a concerted effort to secure approval for the business case and I would like to thank the many people involved in bringing this complex issue to fruition, specifically our local MPs as well as government ministers. We can now look forward to continuing to provide world class cardiothoracic services to patients across the UK, while making a significant contribution to the research and education portfolios already on the campus.”

Keith McNeil, Chief Executive of Cambridge University Hospitals NHS Foundation Trust, said: “I am absolutely delighted that Papworth will be joining us here on the Cambridge Biomedical Campus. This is a fantastic opportunity for not only the academic science agenda here on the campus, but we will also see our clinical teams collaborating more effectively on ground-breaking, translational research to improve the health of people in Cambridge, across the UK and globally.

“Our clinicians have been working closely together over recent months to assess the potential for greater integration to improve patient outcomes and experience in the fields of cardiology, respiratory medicine and transplantation.

“Our aim with this partnership is to build a world-class, cardio-thoracic service, underpinned by cutting-edge science and clinical care.”

Commenting on the announcement, Professor Sir Leszek Borysiewicz, Vice-Chancellor of the University of Cambridge, said:

“This is good news for patients, good news for research and good news for UK plc. The exemplary contribution of Papworth in pioneering heart and lung transplants operations and treatment for these diseases has already made a major global contribution. This move will accelerate new discoveries and pioneering healthcare to the benefits of patients worldwide as well as the UK’s leadership in these fields.”

Professor Patrick Maxwell, Regius Professor of Physic at the University of Cambridge and Chief Executive of Cambridge University Health Partners said:

“This is good news on all fronts. From a patient’s perspective, it is absolutely crucial that they have access to the best possible services in the closest proximity to each other. This will mean that patients will have access to the comprehensive range of services in one place that is essential to achieve the best possible care, and to do so more efficiently.

Cardiovascular disease is one of the major global killers. Bringing such a renowned specialist heart and lung centre onto the site is an excellent complement to the strengths of Cambridge University Health Partners.”

Related documents
Press release published by the Treasury

 

How helpful did you find this page?

Not helpful    12  3 4 5 67  8 9 10    Very helpful